INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 212 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is 1.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $5,133,000 | +16.6% | 45,887 | +5.1% | 0.01% | 0.0% |
Q4 2018 | $4,402,000 | -59.5% | 43,674 | -49.2% | 0.01% | -14.3% |
Q3 2018 | $10,872,000 | +210.3% | 86,036 | +106.0% | 0.01% | +75.0% |
Q2 2018 | $3,504,000 | +191.0% | 41,764 | +113.4% | 0.00% | +100.0% |
Q1 2018 | $1,204,000 | +5.2% | 19,575 | 0.0% | 0.00% | +100.0% |
Q4 2017 | $1,144,000 | +3.9% | 19,575 | +3.2% | 0.00% | 0.0% |
Q3 2017 | $1,101,000 | -50.6% | 18,976 | +3.0% | 0.00% | -66.7% |
Q2 2017 | $2,231,000 | +24.3% | 18,430 | +16.1% | 0.00% | 0.0% |
Q1 2017 | $1,795,000 | +7.2% | 15,871 | +3.0% | 0.00% | 0.0% |
Q4 2016 | $1,674,000 | -27.7% | 15,410 | +9.5% | 0.00% | -25.0% |
Q3 2016 | $2,316,000 | +17.7% | 14,071 | +2.0% | 0.00% | +33.3% |
Q2 2016 | $1,968,000 | +9.6% | 13,792 | -1.3% | 0.00% | 0.0% |
Q1 2016 | $1,796,000 | -13.9% | 13,977 | 0.0% | 0.00% | -25.0% |
Q4 2015 | $2,087,000 | -79.7% | 13,977 | -77.4% | 0.00% | -81.0% |
Q3 2015 | $10,274,000 | -4.6% | 61,943 | +38.9% | 0.02% | +5.0% |
Q2 2015 | $10,767,000 | +297.2% | 44,606 | +364.0% | 0.02% | +300.0% |
Q1 2015 | $2,711,000 | +98.8% | 9,613 | +10.0% | 0.01% | +66.7% |
Q4 2014 | $1,364,000 | -28.7% | 8,741 | +8.2% | 0.00% | -25.0% |
Q3 2014 | $1,912,000 | +2.6% | 8,080 | +2.6% | 0.00% | 0.0% |
Q2 2014 | $1,863,000 | -71.1% | 7,872 | -59.7% | 0.00% | -71.4% |
Q1 2014 | $6,444,000 | -12.2% | 19,539 | -81.8% | 0.01% | -17.6% |
Q4 2013 | $7,338,000 | +210.9% | 107,468 | +214.3% | 0.02% | +183.3% |
Q3 2013 | $2,360,000 | +536.1% | 34,188 | +312.8% | 0.01% | +500.0% |
Q2 2013 | $371,000 | – | 8,282 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |